Can dexmedetomidine be a safe and efficacious sedative agent in post-cardiac surgery patients? a meta-analysis

Yi Yun Lin, Bin He, Jian Chen, Zhi Nong Wang, Yi Yun Lin, Bin He, Jian Chen, Zhi Nong Wang

Abstract

Introduction: The aim of this study was to explore the use of dexmedetomidine as a safe and efficacious sedative agent in post-cardiac surgery patients.

Methods: A systematic literature search of MEDLINE, EMBASE, the Cochrane Library and Science Citation Index until January 2012 and review of studies was conducted. Eligible studies were of randomized controlled trials or cohort studies, comparing dexmedetomidine with a placebo or an alternative sedative agent in elective cardiac surgery, using dexmedetomidine for postoperative sedation and available in full text. Two reviewers independently performed study selection, quality assessment, and data extraction.

Results: The search identified 530 potentially relevant publications; 11 met selection criteria in this meta-analysis. Our results revealed that dexmedetomidine was associated with a shorter length of mechanical ventilation (mean difference -2.70 [-5.05, -0.35]), a lower risk of delirium (risk ratio 0.36 [0.21, 0.64]), ventricular tachycardia (risk ratio 0.27 [0.08, 0.97]) and hyperglycemia (risk ratio 0.78 [0.61, 0.99]), but may increase the risk of bradycardia (risk ratio 2.08 [1.16, 3.74]). But there was no significant difference in ICU stay, hospital stay, and morphine equivalents between the included studies. Dexmedetomidine may not increase the risk of hypotension, atrial fibrillation, postoperative nausea and vomiting, reintubation within 5 days, cardiovascular complications, postoperative infection or hospital mortality.

Conclusions: Dexmedetomidine was associated with shorter length of mechanical ventilation and lower risk of delirium following cardiac surgery. Although the risk of bradycardia was significantly higher compared with traditional sedatives, it may not increase length of hospital stay and hospital mortality. Moreover, dexmedetomidine may decrease the risk of ventricular tachycardia and hyperglycemia. Thus, dexmedetomidine could be a safe and efficacious sedative agent in cardiac surgical patients.

Figures

Figure 1
Figure 1
Flow of studies through the process of retrieval and inclusion in the meta-analysis.
Figure 2
Figure 2
Meta-analysis of postoperative mechanical ventilation, bradycardia and hypotension. (A) Meta-analysis of length of mechanical ventilation (hours). (B) Meta-analysis of postoperative bradycardia. (C) Meta-analysis of postoperative hypotension.
Figure 3
Figure 3
Meta-analysis of postoperative delirium, ventricular tachycardia and hyperglycemia. (A) Meta-analysis of postoperative delirium. (B) Meta-analysis of ventricular tachycardia. (C) Meta-analysis of hyperglycemia.
Figure 4
Figure 4
Funnel plot with length of mechanical ventilation as an endpoint. MD, mean difference; SE, Standard Error.

References

    1. Ostermann ME, Keenan SP, Seiferling RA, Sibbald WJ. Sedation in the intensive care unit: a systematic review. JAMA. 2000;16:1451–1459. doi: 10.1001/jama.283.11.1451.
    1. Pandharipande PP, Pun BT, Herr DL, Maze M, Girard TD, Miller RR, Shintani AK, Thompson JL, Jackson JC, Deppen SA, Stiles RA, Dittus RS, Bernard GR, Ely EW. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA. 2007;16:2644–2653. doi: 10.1001/jama.298.22.2644.
    1. Jackson DL, Proudfoot CW, Cann KF, Walsh T. A systematic review of the impact of sedation practice in the ICU on resource use, costs and patient safety. Crit Care. 2010;16:R59. doi: 10.1186/cc8956.
    1. Hoy SM, Keating GM. Dexmedetomidine: a review of its use for sedation in mechanically ventilated patients in an intensive care setting and for procedural sedation. Drugs. 2011;16:1481–1501. doi: 10.2165/11207190-000000000-00000.
    1. Christensen A. Update on dexmedetomidine for adult ICU sedation. Conn Med. 2009;16:469–472.
    1. Mantz J, Josserand J, Hamada S. Dexmedetomidine: new insights. Eur J Anaesthesiol. 2011;16:3–6.
    1. Wijeysundera DN, Bender JS, Beattie WS. Alpha-2 adrenergic agonists for the prevention of cardiac complications among patients undergoing surgery. Cochrane Database Syst Rev. 2009. p. CD004126.
    1. Wunsch H, Kahn JM, Kramer AA, Rubenfeld GD. Use of intravenous infusion sedation among mechanically ventilated patients in the United States. Crit Care Med. 2009;16:3031–3039. doi: 10.1097/CCM.0b013e3181b02eff.
    1. Tobias JD. Dexmedetomidine and ketamine: An effective alternative for procedural sedation? Pediatr Crit Care Med. 2011.
    1. Tan JA, Ho KM. Use of dexmedetomidine as a sedative and analgesic agent in critically ill adult patients: a meta-analysis. Intensive Care Med. 2010;16:926–939. doi: 10.1007/s00134-010-1877-6.
    1. Abd Aziz N, Chue MC, Yong CY, Hassan Y, Awaisu A, Hassan J, Kamarulzaman MH. Efficacy and safety of dexmedetomidine versus morphine in post-operative cardiac surgery patients. Int J Clin Pharm. 2011;16:150–154. doi: 10.1007/s11096-011-9480-7.
    1. Barletta JF, Miedema SL, Wiseman D, Heiser JC, McAllen KJ. Impact of dexmedetomidine on analgesic requirements in patients after cardiac surgery in a fast-track recovery room setting. Pharmacotherapy. 2009;16:1427–1432. doi: 10.1592/phco.29.12.1427.
    1. Reichert MG, Jones WA, Royster RL, Slaughter TF, Kon ND, Kincaid EH. Effect of a dexmedetomidine substitution during a nationwide propofol shortage in patients undergoing coronary artery bypass graft surgery. Pharmacotherapy. 2011;16:673–677. doi: 10.1592/phco.31.7.673.
    1. Herr DL, Sum-Ping ST, England M. ICU sedation after coronary artery bypass graft surgery: dexmedetomidine-based versus propofol-based sedation regimens. J Cardiothorac Vasc Anesth. 2003;16:576–584. doi: 10.1016/S1053-0770(03)00200-3.
    1. Anger KE, Szumita PM, Baroletti SA, Labreche MJ, Fanikos J. Evaluation of dexmedetomidine versus propofol-based sedation therapy in mechanically ventilated cardiac surgery patients at a tertiary academic medical center. Crit Pathw Cardiol. 2010;16:221–226. doi: 10.1097/HPC.0b013e3181f4ec4a.
    1. Maldonado JR, Wysong A, van der Starre PJ, Block T, Miller C, Reitz BA. Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery. Psychosomatics. 2009;16:206–217. doi: 10.1176/appi.psy.50.3.206.
    1. Wunsch H, Kahn JM, Kramer AA, Wagener G, Li G, Sladen RN, Rubenfeld GD. Dexmedetomidine in the care of critically ill patients from 2001 to 2007: an observational cohort study. Anesthesiology. 2010;16:386–394. doi: 10.1097/ALN.0b013e3181e74116.
    1. Corbett SM, Rebuck JA, Greene CM, Callas PW, Neale BW, Healey MA, Leavitt BJ. Dexmedetomidine does not improve patient satisfaction when compared with propofol during mechanical ventilation. Crit Care Med. 2005;16:940–945. doi: 10.1097/01.CCM.0000162565.18193.E5.
    1. Yapici N, Coruh T, Kehlibar T, Yapici F, Tarhan A, Can Y, Ozler A, Aykac Z. Dexmedetomidine in cardiac surgery patients who fail extubation and present with a delirium state. Heart Surg Forum. 2011;16:E93–98. doi: 10.1532/HSF98.201011102.
    1. Shehabi Y, Grant P, Wolfenden H, Hammond N, Bass F, Campbell M, Chen J. Prevalence of delirium with dexmedetomidine compared with morphine based therapy after cardiac surgery: a randomized controlled trial (DEXmedetomidine COmpared to Morphine-DEXCOM Study) Anesthesiology. 2009;16:1075–1084. doi: 10.1097/ALN.0b013e3181b6a783.
    1. Dasta JF, Jacobi J, Sesti AM, McLaughlin TP. Addition of dexmedetomidine to standard sedation regimens after cardiac surgery: an outcomes analysis. Pharmacotherapy. 2006;16(6):798–805. doi: 10.1592/phco.26.6.798.
    1. Page VJ. Tackling agitated delirium--the tip of the iceberg. Crit Care. 2009;16:158. doi: 10.1186/cc7912.
    1. Rathier MO, Baker WL. A review of recent clinical trials and guidelines on the prevention and management of delirium in hospitalized older patients. Hosp Pract (Minneap) 2011;16:96–106. doi: 10.3810/hp.2011.10.928.
    1. Szumita PM, Baroletti SA, Anger KE, Wechsler ME. Sedation and analgesia in the intensive care unit: evaluating the role of dexmedetomidine. Am J Health Syst Pharm. 2007;16:37–44. doi: 10.2146/ajhp050508.
    1. Afonso J, Reis F. Dexmedetomidine: current role in anesthesia and intensive care. Rev Bras Anestesiol. 2012;16:118–133.
    1. Muntazar M, Kumar FC. Cardiac arrest, a preventable yet a possible risk of dexmedetomidine: fact or fiction? Anesthesiology. 2004;16:1478–1479. author reply 1479-1480.
    1. Ingersoll-Weng E, Manecke GR Jr, Thistlethwaite PA. Dexmedetomidine and cardiac arrest. Anesthesiology. 2004;16:738–739. doi: 10.1097/00000542-200403000-00040.
    1. Bharati S, Pal A, Biswas C, Biswas R. Incidence of cardiac arrest increases with the indiscriminate use of dexmedetomidine: a case series and review of published case reports. Acta Anaesthesiol Taiwan. 2011;16:165–167. doi: 10.1016/j.aat.2011.11.010.
    1. Hammer GB, Drover DR, Cao H, Jackson E, Williams GD, Ramamoorthy C, Van Hare GF, Niksch A, Dubin AM. The effects of dexmedetomidine on cardiac electrophysiology in children. Anesth Analg. 2008;16:79–83. doi: 10.1213/01.ane.0000297421.92857.4e.
    1. Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg. 2000;16:699–705. doi: 10.1097/00000539-200003000-00035.
    1. Martin E, Ramsay G, Mantz J, Sum-Ping ST. The role of the alpha2-adrenoceptor agonist dexmedetomidine in postsurgical sedation in the intensive care unit. J Intensive Care Med. 2003;16:29–41. doi: 10.1177/0885066602239122.
    1. Venn M, Newman J, Grounds M. A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unit. Intensive Care Med. 2003;16:201–207.
    1. Haga KK, McClymont KL, Clarke S, Grounds RS, Ng KY, Glyde DW, Loveless RJ, Carter GH, Alston RP. The effect of tight glycaemic control, during and after cardiac surgery, on patient mortality and morbidity: A systematic review and meta-analysis. J Cardiothorac Surg. 2011;16:3. doi: 10.1186/1749-8090-6-3.
    1. Szekely A, Levin J, Miao Y, Tudor IC, Vuylsteke A, Ofner P, Mangano DT. Impact of hyperglycemia on perioperative mortality after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg. 2011;16:430–437. doi: 10.1016/j.jtcvs.2011.03.009. e431.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe